Glucocerebrosidase

DIAGNOSTIC_TEST3 trials

Sponsors

National Center for Research Resources (NCRR), Assistance Publique - Hôpitaux de Paris, Lysosomal Therapeutics Incorperated

Conditions

Dementia With Lewy BodiesGBA-Associated Parkinson's Disease movement disorderGaucher's Disease

Phase 2

Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

National Center for Research Resources (NCRR)Gaucher's Disease

Start: 1999-11-30Target: 24Updated: 2005-06-24

Unknown Phase

A Randomized, Placebo-Controlled, Double-Blind, Parallel Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of LTI-291 in Patients with Parkinson*s Disease and a GBA1 Mutation

Active, not recruitingNL-OMON44216

Lysosomal Therapeutics IncorperatedGBA-Associated Parkinson's Disease movement disorder

Start: 2017-12-29Target: 40Updated: 2024-02-28

Exploration of GCase Activity to Identify a Subpopulation Eligible for a Therapeutic Trial in Dementia With Lewy Bodies

CompletedNCT05304195

Assistance Publique - Hôpitaux de ParisDementia With Lewy Bodies

Start: 2023-02-17End: 2026-06-17Updated: 2026-06-22